Open-label placebos and eating behaviour. A randomized controlled study

Open-label placebos and eating behaviour. A randomized controlled study - PLEAT

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024101

Enrollment

100

Registered

2021-01-18

Start date

2021-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Desire to lose weight

Interventions

Group 1: The intervention group receives an open-label placebo for three weeks (2 each day) Group 2: control group (no placebos)

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: healthy participants with desire to lose weight

Exclusion criteria

Exclusion criteria: known psychiatric or neurologic diseases, eating disorders, pregnancy

Design outcomes

Primary

Measure	Time frame
BMI-Index, Feelings of hunger (VAS-score) at the beginning and after 3 weeks	—

Secondary

Measure	Time frame
Health-related quality of life (SF-12) at the beginning and after 3 weeks	—

Countries

Germany

Contacts

Public ContactMichael Schaefer

Medical School Berlin

michael.schaefer@medicalschool-berlin.de0306117542

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026